Gastro-Oesophageal Reflux Disease Pipeline Highlights - 2018

  • ID: 4516344
  • Report
  • Fore Pharma
1 of 3
The latest report Gastro-Oesophageal Reflux Disease Pipeline Highlights - 2018, provides most up-to-date information on key pipeline products in the global Gastro-Oesophageal Reflux Disease market. It covers emerging therapies for Gastro-Oesophageal Reflux Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Gastro-Oesophageal Reflux Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Gastro-Oesophageal Reflux Disease pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Gastro-Oesophageal Reflux Disease pipeline products by the company.

Short-term Launch Highlights:
Find out which Gastro-Oesophageal Reflux Disease pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:
  • Gastro-Oesophageal Reflux Disease phase 3 clinical trial pipeline products
  • Gastro-Oesophageal Reflux Disease phase 2 clinical trial pipeline products
  • Gastro-Oesophageal Reflux Disease phase 1 clinical trial pipeline products
  • Gastro-Oesophageal Reflux Disease preclinical research pipeline products
  • Gastro-Oesophageal Reflux Disease discovery stage pipeline products
  • Gastro-Oesophageal Reflux Disease pipeline products short-term launch highlights
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Gastro-Oesophageal Reflux Disease Pipeline by Stages
2. Gastro-Oesophageal Reflux Disease Pipeline by Drug Class
3. Gastro-Oesophageal Reflux Disease Pipeline by Company
4. Gastro-Oesophageal Reflux Disease Phase 3 Clinical Trial Insights
5. Gastro-Oesophageal Reflux Disease Phase 2 Clinical Trial Insights
6. Gastro-Oesophageal Reflux Disease Phase 1 Clinical Trial Insights
7. Gastro-Oesophageal Reflux Disease Preclinical Research Insights
8. Gastro-Oesophageal Reflux Disease Discovery Stage Insights
9. Appendix
10. Research Methodology

List of Tables
Table 1: Gastro-Oesophageal Reflux Disease Phase 3 Clinical Trials, 2018
Table 2: Gastro-Oesophageal Reflux Disease Phase 2 Clinical Trials, 2018
Table 3: Gastro-Oesophageal Reflux Disease Phase 1 Clinical Trials, 2018
Table 4: Gastro-Oesophageal Reflux Disease Preclinical Research, 2018
Table 5: Gastro-Oesophageal Reflux Disease Discovery Stage, 2018

List of Figures
Figures 1: Gastro-Oesophageal Reflux Disease Pipeline Molecules by Clinical Trials Stage, 2018
Figure 2: Gastro-Oesophageal Reflux Disease Pipeline Molecules by Drug Class, 2018
Figure 3: Gastro-Oesophageal Reflux Disease Pipeline Molecules by Company, 2018
Figure 4: Gastro-Oesophageal Reflux Disease Phase 3 Clinical Trial Highlights, 2018
Figure 5: Gastro-Oesophageal Reflux Disease Phase 2 Clinical Trial Highlights, 2018
Figure 6: Gastro-Oesophageal Reflux Disease Phase 1 Clinical Trial Highlights, 2018
Figure 7: Gastro-Oesophageal Reflux Disease Preclinical Research Highlights, 2018
Figure 8: Gastro-Oesophageal Reflux Disease Discovery Stage Highlights, 2018
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll